rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2008-10-3
|
pubmed:abstractText |
An article highlights the pathogenetic aspects of treatment of reflex pain syndromes in the degenerative-dystrophic spinal lesions. Attention is focused on a rational combination of medications that may shorten the duration of analgesic and anti-inflammatory therapy to prevent the development of side-effects caused by non-steroid anti-inflammatory medications. The results of own research of analgesic efficacy and tolerability of treatment in 50 patients with chronic skeletal-muscle pain syndromes in the state of exacerbation assigned to the combination of a non-steroid anti-inflammatory medication mesipol (meloxicam) with a central myorelaxant baclosan (baclofen) are discussed. It was found the positive effect of therapy not only on pain syndrome but on comorbid symptoms as well.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1997-7298
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
48-51
|
pubmed:meshHeading |
pubmed-meshheading:18833172-Back Pain,
pubmed-meshheading:18833172-Baclofen,
pubmed-meshheading:18833172-Cyclooxygenase Inhibitors,
pubmed-meshheading:18833172-Female,
pubmed-meshheading:18833172-Humans,
pubmed-meshheading:18833172-Injections, Intramuscular,
pubmed-meshheading:18833172-Male,
pubmed-meshheading:18833172-Middle Aged,
pubmed-meshheading:18833172-Muscle Relaxants, Central,
pubmed-meshheading:18833172-Recurrence,
pubmed-meshheading:18833172-Syndrome,
pubmed-meshheading:18833172-Thiazines,
pubmed-meshheading:18833172-Thiazoles
|
pubmed:year |
2008
|
pubmed:articleTitle |
[Efficacy and tolerability of the combined therapy with mesipol and baclosan in chronic recurrent vertebrogenic pain syndrome].
|
pubmed:publicationType |
Journal Article,
English Abstract
|